Share This Page
Drug Price Trends for DECONEX DMX
✉ Email this page to a colleague
Average Pharmacy Cost for DECONEX DMX
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DECONEX DMX 17.5-400-10 MG TAB | 50991-0740-01 | 0.67350 | EACH | 2025-02-19 |
| DECONEX DMX 17.5-400-10 MG TAB | 50991-0740-01 | 0.67350 | EACH | 2025-01-22 |
| DECONEX DMX 17.5-400-10 MG TAB | 50991-0740-01 | 0.67350 | EACH | 2024-12-18 |
| DECONEX DMX 17.5-400-10 MG TAB | 50991-0740-01 | 0.67140 | EACH | 2024-08-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Deconex DMX
Introduction to Deconex DMX
Deconex DMX is a combination medication that includes a cough suppressant (dextromethorphan), an expectorant (guaifenesin), and a decongestant (phenylephrine). It is commonly used to treat cough and nasal congestion associated with colds and flu[5].
Market Size and Growth
The market for medications like Deconex DMX is influenced by several factors, including the prevalence of respiratory conditions and the demand for effective over-the-counter (OTC) treatments.
Prevalence of Respiratory Conditions
The global market for dextromethorphan, a key component of Deconex DMX, is expected to grow significantly due to the rising cases of severe cough, upper respiratory tract infections, and other respiratory problems. By 2037, the dextromethorphan market is projected to exceed USD 724.23 million, growing at a CAGR of over 4.4% from 2024 to 2037[4].
Demand for OTC Treatments
The increasing demand for effective OTC medications to treat cough and congestion is a major driver for the growth of the Deconex DMX market. Cough is among the most common medical complaints, accounting for almost 30 million clinical visits per year globally[4].
Market Segmentation
End-User Segmentation
The market for Deconex DMX can be segmented by end-users such as hospitals, retail pharmacies, online pharmacies, and convenience stores. Hospitals are expected to hold a significant share due to the high number of hospital visits for respiratory conditions[4].
Application Segmentation
The market is also segmented by application, with the cough segment anticipated to garner a notable share. The rapid escalation of cough cases due to low immune systems, unhealthy lifestyles, and increasing air pollution is driving this segment[4].
Pricing and Cost Analysis
Current Pricing
The cost for Deconex DMX oral tablets (17.5 mg-400 mg-10 mg) is around $80 for a supply of 100 tablets, depending on the pharmacy. This price is for cash-paying customers and does not include insurance plans. Using a discount card can reduce the cost significantly[2].
Price Projections
Given the growing demand for dextromethorphan and other components of Deconex DMX, prices may remain stable or see a slight increase. However, the availability of discount cards and patient assistance programs can help mitigate the cost for consumers.
Revenue Forecasting Techniques
To estimate the market size and revenue for Deconex DMX, several techniques can be employed:
Bottom-Up Approach
This involves estimating the potential market size by analyzing the total population, incidence and prevalence of the target disease, addressable market size, and penetration rates. It also includes pricing studies, competitive analysis, and reimbursement analysis[3].
Analyst Insights and Research Reports
Cross-checking market estimations with external reports and similar product revenues helps in refining the forecasts. Analyst insights and research reports provide valuable data on market trends and growth drivers[3].
Analogue Markets
Analyzing the market performance of similar products can provide insights into potential market share and revenue for Deconex DMX[3].
Competitive Analysis
Deconex DMX competes with other combination medications like Rynex DM, which contains brompheniramine, dextromethorphan, and phenylephrine. The competitive landscape is influenced by factors such as efficacy, safety, convenience, and physician preference[1].
Segmentation and Penetration Analysis
Customer Segmentation
Identifying segments such as severely affected patients, moderately affected patients, and mildly affected patients helps in refining penetration and share forecasts. Early adopters, particularly those with severe symptoms, are likely to drive initial market penetration[3].
Change Over Time
Analyzing growth drivers and historical penetration of comparable products provides insights into changing and emerging markets. This includes understanding physician prescribing behavior, reimbursement factors, and the impact of commercial efforts[3].
Conclusion
The market for Deconex DMX is poised for growth driven by the increasing prevalence of respiratory conditions and the demand for effective OTC treatments. Here are some key points to consider:
- Growing Market Size: The dextromethorphan market, a key component of Deconex DMX, is expected to exceed USD 724.23 million by 2037.
- Pricing: Current prices are around $80 for 100 tablets, with potential for cost reduction through discount cards.
- Revenue Forecasting: Techniques such as bottom-up analysis, analyst insights, and analogue markets are crucial for accurate revenue projections.
- Competitive Analysis: Deconex DMX competes with other combination medications, with market share influenced by efficacy, safety, and physician preference.
- Segmentation and Penetration: Identifying customer segments and analyzing growth drivers are essential for refining market forecasts.
Key Takeaways
- The global market for dextromethorphan is growing due to increasing respiratory conditions.
- Deconex DMX is priced around $80 for 100 tablets, with potential discounts.
- Revenue forecasting involves bottom-up analysis, analyst insights, and analogue markets.
- Competitive analysis is crucial, focusing on efficacy, safety, and physician preference.
- Customer segmentation and growth driver analysis are key for market penetration.
FAQs
1. What are the active ingredients in Deconex DMX? Deconex DMX contains dextromethorphan (a cough suppressant), guaifenesin (an expectorant), and phenylephrine (a decongestant)[5].
2. What conditions is Deconex DMX used to treat? Deconex DMX is used to treat cough and nasal congestion associated with colds and flu[5].
3. How much does Deconex DMX typically cost? The cost for Deconex DMX oral tablets (17.5 mg-400 mg-10 mg) is around $80 for a supply of 100 tablets, depending on the pharmacy[2].
4. Are there any discount programs available for Deconex DMX? Yes, discount cards and copay programs can help reduce the cost of Deconex DMX. However, no specific patient assistance programs are available for this medication[2].
5. What is the projected market growth for dextromethorphan, a key component of Deconex DMX? The dextromethorphan market is expected to grow at a CAGR of over 4.4% from 2024 to 2037, exceeding USD 724.23 million by 2037[4].
Sources
- Drugs.com - Deconex DMX vs Rynex DM Comparison
- Drugs.com - Deconex DMX Prices, Coupons, Copay Cards & Patient Assistance
- iHealthcareAnalyst - Revenue Forecasting Techniques for New Pharmaceutical Drugs
- ResearchNester - Dextromethorphan Market Size, Growth Forecasts 2025-2037
- BuzzRx - Deconex DMX Drug Details & Information
More… ↓
